Acute Pain, Opioid Use
Conditions
Keywords
Hip arthroscopy, intra-articular injection, PENG block
Brief summary
Hip arthroscopy is a popular surgical method that is increasingly being used for both intraarticular and extraarticular hip surgeries. Postoperative acute pain is difficult to control in hip surgeries due to the complex nature of hip innervation and the large number of surgical interventions. Optimal treatment of postoperative pain in hip arthroscopy is very important to be able to perform rehabilitation, avoid opioid side effects and minimize unplanned re-hospitalization. Regional anesthesia techniques are widely used because of their proven efficacy in post-surgical pain management and their safety profile that ultimately contributes to early recovery. Many regional techniques such as neuraxial blocks, lumbar plexus block, femoral nerve block, fascia iliac block and intraarticular local anesthetic injection have been used for the treatment of acute postoperative pain. Femoral nerve and fascia iliac blocks have shown good results for long-term post-surgery analgesia. However, the obturator nerve and accessory obturator nerve should be targeted to achieve more effective perioperative pain control. There are studies reporting that pericapsular nerve group block (PENG), which has been defined in recent years, provides effective perioperative analgesia in hip surgeries. In this study, we aim to compare the effectiveness of PENG block and intra-articular local anesthetic injection in hip arthroscopy.
Interventions
PENG block will be made with 15 ml 0.5% bupivacaine + 2 mg dexamethasone + 14.5 ml NaCl under US-guidance
Intra-articular local anesthetic injection will be made with 10 ml 0.5% bupivacaine + 2 mg dexamethasone + 9.5 ml NaCl
Sponsors
Study design
Eligibility
Inclusion criteria
* American Association of Anesthesiologists (ASA) physical status I - III * BMI 20 to 35 kg / m2 * Patients scheduled for elective hip arthroscopy * Able to provide informed consent.
Exclusion criteria
* Patients who refuse to participate in the study, * Coagulopathy, * Sepsis, * Hepatic or renal insufficiency, * Pregnancy * Allergy to local anesthetic drugs, * Chronic pain condition requiring opioid intake at home, * BMI above 40. * History of psychiatric diseases needing treatment. * Failure of nerve block * Substance abuse history * Hip revision surgery * Underlying neurologic disorder affecting pain perception. * Angina, heart attack, heart failure * Kidney or hepatic insufficiency * Stroke * Gastrintestinal bleeding history
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative opioid consumption | up to the first 24 hours postoperatively | Total amount of morphine consumption during the first 24 hours after surgery. Patient controlled analgesia to be inserted. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity score | 0.5, 1, 3, 6, 12, 24 hours postoperatively. | Postoperative pain assessed with verbal rating scale (VRS 0: no pain 10:pain as bad as can be ) at 0.5, 1, 3, 6, 12, 24 hours postoperatively. |
| First rescue analgesic time | up to the first 24 hours postoperatively | The investigators will collect time to first rescue analgesic consumption in each group |
| Postoperative nausea and vomiting | up to the first 24 hours postoperatively | Nausea and vomiting intensity score measured by numeric rank score (0:no nausea and no vomiting, 1: have nausea, no vomiting, 2: once vomiting, 3: two or more vomiting). |
| Patient satisfaction | at the end of 24 hours postoperatively | Patient satisfaction measured using a numeric rating scale 0 to 10 (0 = unsatisfied; 10 =very satisfied) |
Countries
Turkey (Türkiye)